|
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid |
|
CHEBI:91274 |
|
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid |
|
A polyunsaturated hydroxy fatty acid that consists of (7Z,10Z,14E,16Z,19Z)-docosapentaenoic acid bearing a single hydroxy substituent at the 13R-position. |
|
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C22H34O3/c1-2-3-4-5-9-12-15-18-21(23)19-16-13-10-7-6-8-11-14-17-20-22(24)25/h3-4,6-7,9,12-13,15-16,18,21,23H,2,5,8,10-11,14,17,19-20H2,1H3,(H,24,25)/b4-3-,7-6-,12-9-,16-13-,18-15+/t21-/m0/s1 |
FYXSGJODUCMLMK-RFPXNJKWSA-N |
C(\CC)=C\C\C=C/C=C/[C@@H](C/C=C\C/C=C\CCCCCC(=O)O)O |
|
Bronsted acid
A molecular entity capable of donating a hydron to an acceptor (Bronsted base).
(via oxoacid )
|
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
|
|
View more via ChEBI Ontology
Outgoing
|
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid
(CHEBI:91274)
has functional parent
(7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid
(CHEBI:53488)
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid
(CHEBI:91274)
has role
human xenobiotic metabolite
(CHEBI:76967)
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid
(CHEBI:91274)
has role
mouse metabolite
(CHEBI:75771)
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid
(CHEBI:91274)
is a
hydroxydocosapentaenoic acid
(CHEBI:134651)
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid
(CHEBI:91274)
is conjugate acid of
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate
(CHEBI:90824)
|
|
Incoming
|
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate
(CHEBI:90824)
is conjugate base of
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoic acid
(CHEBI:91274)
|
(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosa-7,10,14,16,19-pentaenoic acid
|
(13R)-hydroxy-(7Z,10Z,14E,16Z,19Z)-docosapentaenoic acid
|
ChEBI
|
26236990
|
PubMed citation
|
Europe PMC
|
|